Stockscreener 앱 받기
38.63
1.74%
0.66
전일 마감가:
$37.97
열려 있는:
$38.93
하루 거래량:
377.26K
Relative Volume:
0.95
시가총액:
$1.13B
수익:
$219.79M
순이익/손실:
$-57.47M
주가수익비율:
-17.97
EPS:
-2.15
순현금흐름:
$-19.25M
1주 성능:
-0.03%
1개월 성능:
+10.94%
6개월 성능:
+105.26%
1년 성능:
+32.66%
1일 변동 폭
$38.06
$39.19
1주일 범위
$36.63
$39.19
52주 변동 폭
$14.59
$40.61
Castle Biosciences Inc Stock (CSTL) Company Profile
명칭
Castle Biosciences Inc
전화
866-788-9007
주소
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
CSTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
38.63 | 1.11B | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-04-30 | 개시 | Lake Street | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 재확인 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | BTIG Research | Buy |
| 2019-08-19 | 개시 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | Robert W. Baird | Outperform |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
모두보기
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Castle Biosciences, Inc. $CSTL Shares Bought by Braidwell LP - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Castle Biosciences (CSTL) Highlights Breakthrough in Barrett's E - GuruFocus
Castle Biosciences Announces Publication of Study Confirming TissueCypher® Test's Efficacy in Risk Stratification for Barrett's Esophagus Patients - Quiver Quantitative
BTIG Maintains Castle Biosciences (CSTL) Buy Recommendation - Nasdaq
Systematic Review and Meta-Analysis Confirms TissueCypher® - GlobeNewswire
Expert Melanoma Panel Recommends Castle Biosciences DecisionDx-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma - marketscreener.com
Castle Biosciences Announces Endorsement of DecisionDx-Melanoma Test in Independent Expert Consensus Paper - Quiver Quantitative
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma - Yahoo Finance
Castle Biosciences (NASDAQ:CSTL) Insider Sells $53,600.17 in Stock - MarketBeat
Here's Why 'Trend' Investors Would Love Betting on Castle Biosciences (CSTL) - Yahoo Finance
New York State Common Retirement Fund Acquires 52,671 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Purchased by Schroder Investment Management Group - MarketBeat
Will Castle Biosciences Inc. stock attract more institutional investorsFed Meeting & Reliable Price Breakout Signals - Newser
XTX Topco Ltd Increases Stock Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Geode Capital Management LLC Boosts Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
8,362 Shares in Castle Biosciences, Inc. $CSTL Purchased by Elevation Point Wealth Partners LLC - MarketBeat
Castle Biosciences stock hits 52-week high at 40.61 USD By Investing.com - Investing.com Australia
Castle Biosciences stock hits 52-week high at 40.61 USD - Investing.com
Summit Global Investments Lowers Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Derek Maetzold Sells 5,115 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Is Castle Biosciences Inc. stock a buy before product launches2025 Analyst Calls & Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Castle Biosciences (NASDAQ:CSTL) Hits New 52-Week HighTime to Buy? - MarketBeat
CSTL Form 4: CEO stock sale and updated insider holdings - Stock Titan
Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 4,693 Shares - MarketBeat
CEO Maetzold Files To Sell 10,712 Of Castle Biosciences Inc [CSTL] - TradingView
How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08% - MSN
Castle Biosciences Executive Sells Shares - TradingView
Officer Juvenal Sells 4,693 ($167K) Of Castle Biosciences Inc [CSTL] - TradingView
[Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Top 5 Articles of the Week: November 16-21 - Dermatology Times
Is Pune Es Valuation Cheap Compared to Growth PeersChart Pattern Recognition & Superior Wealth Building - earlytimes.in
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Castle Biosciences partners with SciBase for diagnostic tests - MSN
What Makes Castle Biosciences (CSTL) a New Strong Buy Stock - MSN
Castle Biosciences, Inc. (086.F) stock price, news, quote and history - Yahoo Finance UK
Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year HighTime to Buy? - MarketBeat
Castle Biosciences stock hits 52-week high at $35.68 By Investing.com - Investing.com Canada
Castle Biosciences stock hits 52-week high at $35.68 - Investing.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Castle Biosciences earns Houston Top Workplace title for fifth year - Traders Union
Castle Biosciences (CSTL): Evaluating Valuation as New Melanoma Test Data Gains Attention at Major Oncology Congress - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Castle Biosciences, Inc. (CSTL) Competitors - Meyka
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year - The Manila Times
Zacks.com featured highlights include Perimeter Solutions, Interface, Castle Biosciences and Great Lakes Dredge & Dock - sharewise.com
Castle Biosciences, Inc. $CSTL Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Will Castle Biosciences Inc. stock remain a Wall Street favorite2025 Volatility Report & Reliable Trade Execution Plans - newser.com
Castle Biosciences Inc. recovery potential after sell off2025 Biggest Moves & AI Driven Stock Reports - newser.com
Castle Biosciences Inc (CSTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.39%
자본화:
|
볼륨(24시간):